Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fletcher

Showing results (1101-1110 of 1,501) with videos related to

Pageof 151
Sort By:
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
Frontiers in Immunology|May 21, 2019
<i>In vitro</i> Mycobacterial Growth Inhibition in South Korean Adults With Latent TB InfectionHyejon Lee, Jungho Kim, Young Ae Kang, et al.
Plos One|June 5, 2012
p53 modulation as a therapeutic strategy in gastrointestinal stromal tumorsJoern Henze, Thomas Mühlenberg, Susanne Simon, et al.
Psychosomatic Medicine|March 1, 1997
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane AndrewG Ironson, C Wynings, N Schneiderman, et al.
World Neurosurgery|June 15, 2025
Poor Correlation Between Inflammatory and Brain Injury Biomarkers After Neonatal Intraventricular Hemorrhage: A Pilot StudyAnkit Agarwal, Miriam Zamorano, Aidan Collier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
MED12 mutations in leiomyosarcoma and extrauterine leiomyomaGloria Ravegnini, Adrian Mariño-Enriquez, Jaime Slater, et al.
The American Journal of Pathology|March 7, 2000
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumorsM L Lux, B P Rubin, T L Biase, et al.
Experimental Physiology|December 8, 2017
Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient miceJustin A Fletcher, Melissa A Linden, Ryan D Sheldon, et al.
Allergy|February 1, 1995
Immunoglobulin E levels in relationship to HIV-1 disease, route of infection, and vitamin E statusM J Miguez-Burbano, G Shor-Posner, M A Fletcher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
BAFF augments certain Th1-associated inflammatory responsesAndrew P R Sutherland, Lai Guan Ng, Carrie A Fletcher, et al.
Pageof 151

Showing results (1101-1110 of 1,501) with videos related to

Sort By:
Pageof 151
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
Frontiers in Immunology|May 21, 2019
<i>In vitro</i> Mycobacterial Growth Inhibition in South Korean Adults With Latent TB InfectionHyejon Lee, Jungho Kim, Young Ae Kang, et al.
Plos One|June 5, 2012
p53 modulation as a therapeutic strategy in gastrointestinal stromal tumorsJoern Henze, Thomas Mühlenberg, Susanne Simon, et al.
Psychosomatic Medicine|March 1, 1997
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane AndrewG Ironson, C Wynings, N Schneiderman, et al.
World Neurosurgery|June 15, 2025
Poor Correlation Between Inflammatory and Brain Injury Biomarkers After Neonatal Intraventricular Hemorrhage: A Pilot StudyAnkit Agarwal, Miriam Zamorano, Aidan Collier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
MED12 mutations in leiomyosarcoma and extrauterine leiomyomaGloria Ravegnini, Adrian Mariño-Enriquez, Jaime Slater, et al.
The American Journal of Pathology|March 7, 2000
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumorsM L Lux, B P Rubin, T L Biase, et al.
Experimental Physiology|December 8, 2017
Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient miceJustin A Fletcher, Melissa A Linden, Ryan D Sheldon, et al.
Allergy|February 1, 1995
Immunoglobulin E levels in relationship to HIV-1 disease, route of infection, and vitamin E statusM J Miguez-Burbano, G Shor-Posner, M A Fletcher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
BAFF augments certain Th1-associated inflammatory responsesAndrew P R Sutherland, Lai Guan Ng, Carrie A Fletcher, et al.
Pageof 151